These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27982704)

  • 1. Tramadol, an Opioid Receptor Agonist: An Inhibitor of Growth, Morphogenesis, and Biofilm Formation in the Human Pathogen, Candida albicans.
    Kathwate GH; Karuppayil SM
    Assay Drug Dev Technol; 2016 Dec; 14(10):567-572. PubMed ID: 27982704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
    De Brucker K; De Cremer K; Cammue BP; Thevissen K
    Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptic Drugs Inhibit Growth, Dimorphism, and Biofilm Mode of Growth in Human Pathogen Candida albicans.
    Kathwate GH; Shinde RB; Karuppayil SM
    Assay Drug Dev Technol; 2015; 13(6):307-12. PubMed ID: 26241210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Asarone, an active principle of Acorus calamus rhizome, inhibits morphogenesis, biofilm formation and ergosterol biosynthesis in Candida albicans.
    Rajput SB; Karuppayil SM
    Phytomedicine; 2013 Jan; 20(2):139-42. PubMed ID: 23123225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel properties of Hippophae rhamnoides L. twig and leaf extracts - anti-virulence action and synergy with antifungals studied in vitro on Candida spp. model.
    Sadowska B; Budzyńska A; Stochmal A; Żuchowski J; Różalska B
    Microb Pathog; 2017 Jun; 107():372-379. PubMed ID: 28428132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin.
    Messier C; Epifano F; Genovese S; Grenier D
    Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans.
    Raut JS; Shinde RB; Chauhan NM; Karuppayil SM
    Biofouling; 2013; 29(1):87-96. PubMed ID: 23216018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.
    Yang LF; Liu X; Lv LL; Ma ZM; Feng XC; Ma TH
    J Mycol Med; 2018 Mar; 28(1):36-44. PubMed ID: 29477784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
    Sun L; Liao K; Wang D
    PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-antifungal drugs inhibit growth, morphogenesis and biofilm formation in Candida albicans.
    Kathwate GH; Shinde RB; Mohan Karuppayil S
    J Antibiot (Tokyo); 2021 May; 74(5):346-353. PubMed ID: 33469194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
    Tian B; Yan Q; Wang J; Ding C; Sai S
    Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
    [No Abstract]   [Full Text] [Related]  

  • 14. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans.
    de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA
    J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 2, 4-di-tert-butylphenol on growth and biofilm formation by an opportunistic fungus Candida albicans.
    Padmavathi AR; Bakkiyaraj D; Thajuddin N; Pandian SK
    Biofouling; 2015; 31(7):565-74. PubMed ID: 26299260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIG1, TUP1 and NRG1 mediated yeast to hyphal morphogenesis inhibition in Candida albicans by ganciclovir.
    Gavandi T; Patil S; Basrani S; Yankanchi S; Chougule S; Karuppayil SM; Jadhav A
    Braz J Microbiol; 2024 Sep; 55(3):2047-2056. PubMed ID: 38789908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation.
    Lippert R; Vojnovic S; Mitrovic A; Jux N; Ivanović-Burmazović I; Vasiljevic B; Stankovic N
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3506-11. PubMed ID: 24929472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11.
    Morici P; Fais R; Rizzato C; Tavanti A; Lupetti A
    PLoS One; 2016; 11(11):e0167470. PubMed ID: 27902776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
    Messier C; Grenier D
    Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.